Author

J. Mateus

h-index 3 View on Semantic Scholar

We have 3 of 8 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Interim BNT162b2 LP.8.1-adapted COVID-19 Vaccine Effectiveness among Non-Immunocompromised Older Adults in California and Louisiana, August-December 2025

VE against COVID-19-related ED/UC encounters was 48% (95% CI:19, 66) and VE against COVID-19-related ED/UC encounters was 48% (95% CI:19, 66).

L. Zambrano, T. Yu, J. Mateus et al. · medRxiv · 0 citations

Open access Aug 2026

2024-2025 BNT162b2 KP.2 COVID-19 full season vaccine effectiveness from vaccine registries linked to administrative claims in two states: A cohort study in non-immunocompromised adults.

BNT162b2 provided protection against COVID-19-associated outcomes of ED, UC or hospitalization among non-immunocompromised U.S. adults, including those with UMCs, over the course of the 2024-2025 respiratory virus season, supporting continued vaccine recommendations.

Tara Ahi, K. Andersen, J. Mateus et al. · Vaccine · 0 citations

Jul 2026

KP.2-Adapted BNT162b2 COVID-19 Vaccine Uptake and Effectiveness in Children.

KP.2-adapted BNT162b2 COVID-19 vaccine provided significant protection against emergency department, urgent care, and inpatient encounters for COVID-19 in children.

K. Andersen, Tara Ahi, Maria D. McColgan et al. · Jornal de Pediatria · 0 citations